Verastem shares surge more than 50% after pancreatic-cancer treatment study data

Verastem shares surge more than 50% after pancreatic-cancer treatment study data
By: market watch Posted On: May 23, 2024 View: 20

[unable to retrieve full-text content]

Shares of Verastem rose late Thursday after interim data from the company’s trial evaluating a combination therapies to treat pancreatic cancer showed a high overall response rate.

Read this on market watch Header Banner
  Contact Us
  • Contact Form
  Follow Us
  About

Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.